Replies to post #289663 on Avid Bioservices Inc (CDMO)

[biopharm]

I say the big picture sits with the FDA and the decision to make blood tests / liquid biopsies / biomarkers... surrogate endpoints for clinical trials--- let's start with lung cancer
http://media.jamanetwork.com/news-item/blood-samples-as-surrogates-for-tumor-biopsies-in-patients-with-lung-cancer/

[Tough_to_make_money]

JMO, Geo..

Is it possible, a decision is made, and rif/raf (weak hands) needs to be cleared out. How do you accomplish this.
A. A RS is done in accordance to plan.
B. A strong PR is released at a strategic time leaving those on the wish list in the dust and those on verge of selling, selling! Meaning yes, above five dollars.
Accomplishing both... Locking out new undeserving and too late investors and..........those happy to sell at the five plus ps.
Sound reasonable, possible or insane..Big boy pants on bloused to the ankle. Give it to me.